Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia
- 1 October 1998
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 44 (8) , 667-674
- https://doi.org/10.1016/s0006-3223(98)00151-6
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Schizophrenia – a Brain Disease? a Critical Review of Structural and Functional Cerebral Abnormality in the DisorderThe British Journal of Psychiatry, 1995
- Computed tomography measurements of brain density in schizophreniaBiological Psychiatry, 1991
- Ventricular Enlargement in Schizophrenia Evaluated With Computed Tomographic ScanningArchives of General Psychiatry, 1990
- Magnetic Resonance Imaging of the Brain in SchizophreniaArchives of General Psychiatry, 1990
- Genetic and Perinatal Determinants of Structural Brain Deficits in SchizophreniaArchives of General Psychiatry, 1989
- A “Glutamatergic Hypothesis” of SchizophreniaClinical Neuropharmacology, 1989
- Structural brain pathology in schizophrenia revisited *1Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acidNeuropsychopharmacology, 1987
- Negative Symptoms in SchizophreniaArchives of General Psychiatry, 1982
- Ventricular enlargement in schizophrenia: relationship to positive and negative symptomsAmerican Journal of Psychiatry, 1982
- Glutamate in schizophrenics and healthy controlsArchiv Fur Psychiatrie Und Nervenkrankheiten, 1982